Linagliptin 2.5 mg

Linagliptin 2.5 mg 
LINALIGLIP is a medication that belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors. LINALIGLIP is used in the treatment of type 2 diabetes mellitus. LINALIGLIP helps lower blood sugar levels by inhibiting the action of the DPP-4 enzyme, which breaks down the hormone GLP-1 (glucagon-like peptide-1). By inhibiting DPP-4, LINALIGLIP increases the levels of GLP-1, which stimulates insulin release and reduces the production of glucose by the liver.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/linaliglip-2-5-134280